CALC vs DGX · $22.5M cap vs P/E 22, rev $5.94B
CalciMedica, Inc. Common Stock (CALC) versus Quest Diagnostics Incorporated (DGX) — a side-by-side from cached financials, not a winner call.
CalciMedica, Inc. Common Stock (CALC) is a biotechnology company listed on US.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
CALC does not have a complete income-statement cache yet.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
CALC currently screens at market cap $22.5M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Not investment advice. Open the CALC and DGX stock pages for the full models.
Not investment advice.